Onward: Funding, Investors & Team (Sep 2026)
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and utilizes training tools to help rehabilitate patients with neurological conditions like spinal cord injury (SCI).
Onward has raised $163M across 7 funding rounds on record, the most recent an undisclosed round of $47.8M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Onward Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Onward Funding Rounds
1 of 7 rounds was announced without a disclosed amount and is excluded from the total.
Onward raised $31.9M in an undisclosed round announced in Apr 2021.
1.2 years later, a Grant of $1.3M was announced in Jun 2022.
1.8 years later, an undisclosed round of $21.7M was announced in Mar 2024.
6 months later, an undisclosed round was announced in Sep 2024 with no disclosed amount.
2 months later, an undisclosed round of $2.1M was announced in Nov 2024.
11 months later, an undisclosed round of $58.1M was announced in Oct 2025.
6 months later, an undisclosed round of $47.8M was announced in Apr 2026.
Onward Founders and Leadership Team
Contact details for the Onward team: 2 of 3 have an email address on file.
Start 14-day free trial →Onward Funding Compared to Other Biotechnology Startups
Onward's latest round of $47.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Onward in Biotechnology and Eindhoven
Companies Similar to Onward
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and…
Onward Funding FAQs
What does Onward do?
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and utilizes training tools to help rehabilitate patients with neurological conditions like spinal cord injury (SCI).
How much funding has Onward raised?
Onward has raised $163M across 7 rounds on record. The most recent is an undisclosed round of $47.8M announced in Apr 2026.
When did Onward last raise funding?
Onward's most recent funding round on record is an undisclosed round of $47.8M, announced in Apr 2026.
Who founded Onward?
FundedIQ lists Gregoire Courtine (Founder), Vincent Delattre (Founder) at Onward.
Who is the CEO of Onward?
Dave Marver is listed as CEO at Onward.
Where is Onward headquartered?
Onward is based in Eindhoven, Noord-Brabant, Netherlands.
How many employees does Onward have?
Onward is in the 101-250 employee band.
How does Onward's funding compare to other Biotechnology startups?
Onward's latest round of $47.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Onward Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Onward is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.